X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-06 | STSA | Takanashi Ken | Dir, 10% | P - Purchase | $0.91 | +22,053,581 | 24,847,694 | +789% | +$20,068,759 | |||||
| M | 2023-06-06 | STSA | Shin Nippon Biomedical Laboratories, Ltd. | 10% | P - Purchase | $0.91 | +30,477,313 | 11,217,845 | -158% | +$27,734,355 | |||||
2022-11-21 | STSA | Leonard Braden Michael | 10% | P - Purchase | $0.71 | +150,000 | 6,590,000 | +2% | +$106,740 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |